Katsuyuki Shiratori

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)

M. Satake, Y. Takamatsu, S. Kutsuna, 2022, Life.

How we secured a COVID‐19 convalescent plasma procurement scheme in Japan

M. Satake, S. Kutsuna, N. Ohmagari, 2021, Transfusion.

Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma

Y. Takamatsu, S. Kutsuna, N. Ohmagari, 2022, Transfusion and Apheresis Science.

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial

Akiko Kimura, M. Satake, Y. Takamatsu, 2023, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial

S. Kutsuna, N. Ohmagari, I. Hamaguchi, 2023 .